Anatomic Pathology Market
Market Insights on Anatomic Pathology covering sales outlook, demand forecast & up-to-date key trends
Anatomic Pathology Market by Product & Service, Application, End User & Region - Forecast 2022 - 2030
Anatomic Pathology Market Outlook (2022-2030)
[290 Pages Report] The global anatomic pathology market size reached a valuation of US$ 32.5 Mn in 2022 and is likely to grow at a robust CAGR of 8.2% between 2022 and 2030, surpassing US$ 61.1 Mn by the end of 2030. Growth in the global anatomic pathology market is driven by rising application of anatomic pathology in disease diagnosis and drug discovery and development.
|
Anatomic Pathology Market Size (2022) |
US$ 32.5 Mn |
|
Anatomic Pathology Market Revenue Forecast (2030) |
US$ 61.1 Mn |
|
Anatomic Pathology Market Growth Rate (2022-2030) |
8.2% CAGR |
|
North America Market Share |
37.1% |
Anatomic pathology is a medical specialty that focuses on identifying diseases on the basis of microscopic, macroscopic, immunologic, biochemical, and molecular examinations of organs and tissues. Its (anatomical pathology) main role is to identify abnormalities that can help to diagnose disease and manage treatment.
The adoption of anatomic pathology has shown promising results in identifying and managing various types of tumors or cancers, kidney and liver diseases, autoimmune disorders etc. As a result, it is often being used in end use verticals such as hospitals, research laboratories, and diagnostic laboratories.
Rising prevalence of numerous diseases coupled with growing need for early detection of chronic diseases and rapidly expanding healthcare industry is providing a strong thrust to the growth of anatomic pathology market and the trend is likely to continue during the forecast period.
Consequently, increasing usage of biomarkers, advances in histology, and rapid expansion of cellular pathology market will positively impact the anatomic pathology market projections in future. Over the years, biomarkers have become quite popular as they allow pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes.
Currently, anatomic pathology accounts for 0.2% share of the global pathology market and this number is expected to increase substantially on account of rising applications of anatomic pathology in numerous applications.
Regionally, North America will continue to dominate the global anatomic pathology market, accounting for around 37.1% share through 2030. Growth in the North American anatomic pathology market is driven by strong presence of major market players, favorable government policies connected to pathological training programs, availability of advanced technologies, favorable reimbursement scenarios for anatomic pathology diagnostic tests, and rising healthcare expenditures
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
8.21% |
|
H1, 2022 Projected |
8.20% |
|
H1, 2022 Outlook |
7.80% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 40 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 41 ↓ |
The comparative analysis and market growth rate of global anatomic pathology market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 41 Basis Point Share (BPS).
The key developments in the market include the design of Biophotonics in pathology to describe various types of imaging methods available. This factor has enforced the factor of pathology and radiology to converge towards a more holistic approach to diagnostic imaging, thus playing as a major driving factor for growth of the market.
The market observes a decline in the BPS values owed to the decreased flexibility in work force staffing, when compared with general service providers such as laboratories, high operational costs and overheads with each unit of subspecialty operating, and a greater need for trained staff, among others.
Several new approaches, such as cryoelectron tomography, holographic tissue dynamics spectroscopy, cellular magnetic resonance imaging, exotic material lensing, and photoacoustic tomography are further set to propel the market growth over the coming years.
Anatomic Pathology Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)
The global demand for anatomic pathology products and services is projected to grow at a healthy CAGR of 8.2% during the forecast period between 2022 and 2030, totaling over US$ 61.1 Bn by 2030. Factors such as rising prevalence of cancer and other target diseases, growing demand for personalized medicine, escalating need for early diagnosis of chronic diseases, surge in R&D activities, and introduction of favorable reimbursement policies are driving the anatomic pathology industry growth.
Anatomic pathology has become one of the most commonly used techniques for the detection and management of diseases like cancer. It allows pathologists to determine the cause and effect of particular diseases by analyzing tissues and organs during biopsies and other medical procedures.
Rapid surge in cancer cases across the globe is providing a major impetus to the growth of anatomic pathology market and the trend is likely to continue during the forecast period. According to the American Cancer Society, it is estimated that the global cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This will create immense demands for advanced diagnostic technologies and treatment approaches, thereby expanding the anatomic pathology market size.
Furthermore, advancements in anatomic pathology instruments will significantly aid in improving the anatomic pathology market share during the forecast period. Leading anatomic pathology manufacturers are continuously focusing on introducing advanced digital products such as specimen tracking systems (STS), to empower anatomical pathologists to accurately diagnose diseases and make confident treatment decisions.
Additionally, growing awareness, increasing healthcare expenditure, escalating cancer research, and rise in the use of biomarkers during illness diagnosis will boost the anatomic pathology market growth during the forthcoming years.
Based on the aforementioned factors, FMI’s latest report on anatomic pathology market forecast the global anatomic pathology market to expand at 1.88X by 2030.
Which Factors are Challenging the Growth of Anatomic Pathology Market?
Despite its optimistic stance, the global anatomic pathology market is facing various obstacles that are challenging its growth to some extent. Some of these obstacles include the availability of refurbished anatomic pathology equipment, frequent product recalls, and adoption of alternative diagnostic techniques.
Today, various refurbished anatomic pathology devices such as tissue processors, microtomes, and staining systems are available from LabX (US), Rankin Biomedical Corporation (US), Swerdlick Medical Systems (US), and AL-TAR (US). Availability of these refreshed anatomic pathology products is expected to negatively impact the revenue of companies selling branded anatomic pathology devices.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Analysis
How is the Growth Projection for the U.S. Anatomic Pathology Market?
“Rising Investments in Research and Development Creating Space for Anatomic Pathology Market Growth in the U.S.”
As per FMI, the U.S. is expected to account for a significant share of the global anatomic pathology market through 2030, owing to the rising prevalence of cancer, high research and development funding, availability of favorable reimbursement policies, increasing adoption of pathology imaging systems, surge in anatomic pathology labs, flourishing human anatomical models market, and strong presence of leading anatomic pathology m market players.
Over the years, the U.S. has become a global leader in medical research. The country annually spends billions of dollars on research and development to advance personalized medicine and reduce the burden of chronic diseases. For instance, the National Institutes of Health (NIH) alone spends about US$ 41.7 billion annually in medical research for the American people.
Similarly, rise in the number of new anatomic pathology product launches and approvals will improve the anatomic pathology market share of the U.S. during the forecast period.
How Will Growth Unfold in the Germany Anatomic Pathology Market?
“Availability of Advanced Pathology Devices and Increasing Number of Anatomic Pathology Service Providers Spurring Growth in the Germany Anatomic Pathology Market”
With rising prevalence of chronic diseases and availability of advanced pathology devices, the anatomic pathology market in Germany is expected to grow at a strong CAGR during the forecast period between 2022 and 2030.
As the burden of cancer and other chronic diseases across Germany continue to rise, medical institutes and government organizations are putting various efforts to tackle the situation. They are increasingly investing in advanced diagnostic technologies to improve the diagnostic screening and reduce healthcare burden. This is creating a conducive environment for the anatomic pathology industry growth in the country.
The Europe anatomic pathology market, spearheaded by Germany and the U.K. is expected to account for 25.7% of the global market share.
Category-wise Analysis
Based on Product and Service, Which Segment Accounts for the Largest Share of Anatomic Pathology market?
“Demand for Anatomic Pathology Services to Remain High Throughout the Forecast Period”
As per FMI, the anatomic pathology services segment is likely to account for the largest share of the global anatomic pathology market during the forecast period, owing to the rapid surge in cancer cases, availability of favorable reimbursement for diagnostic tests, and increase in the number of anatomic pathology service providers worldwide.
Which is the Most Lucrative Application of Anatomic Pathology?
“Disease Diagnosis Segment to Contribute Most to the Global Anatomic Pathology Market”
Based on application, the global anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. Among these, disease diagnosis segment accounted for the largest share in 2021, and is likely to grow at a relatively higher CAGR during the assessment period, as per the latest anatomic pathology market trends. This can be attributed to rising incidence of cancer and other chronic diseases, growing need for early diagnosis of these diseases to initiate proper treatment, and various initiatives launched by government to facilitate diagnostic screening of chronic disease.
Similarly, expansion of cancer tissue diagnostics market and advancements in tissue diagnostics will support the growth of this segment during the forthcoming years.
Which End User Segment Dominates the Global Anatomic Pathology Market?
“Demand for Anatomic Pathology Products and Services to Remain High in Hospitals”
Based on end user, anatomic pathology market has been segmented into hospitals, research laboratories, diagnostic laboratories, and others. As per FMI, hospital segment held the largest share of anatomic pathology market in 2021 and the trend is likely to continue during the forecast period, owing to the rising number of patient visits to hospitals, growing awareness among people regarding the importance of early diseases diagnosis, and rapid increase in the number of hospitals worldwide.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Who are Some of the Leading Players in Anatomic Pathology Market?
Some of the leading anatomic pathology providers include Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics, Bio SB, and Agilent Technologies.
Players like Roche have become global leaders in solutions for anatomical pathology labs to diagnose cancers. They are continuously investing in research and development to advance in personalized healthcare and integrate digital tools in anatomic pathology. For instance,
- In 2021, Roche launched two new automated digital pathology algorithms called uPath HER2 image analysis and uPath HER2 Dual ISH image analysis, to support pathologists in making fast and accurate patient diagnoses in breast cancer.
- In 2022, Roche collaborated with Bristol Myers Squibb to advance personalized healthcare through digital pathology solutions.
Similarly, various leading players are adopting strategies like new product launches, acquisitions, mergers, partnerships, and collaborations to gain a competitive edge in the global anatomic pathology market. For instance,
- In 2021, Inform diagnostics, a leading U.S. anatomic pathology provider, collaborated with Paige, a global leader in AI-based cancer diagnostics software for digital pathology, to integrate digital solutions with anatomic pathology diagnostics.
- In June 2022, EmeritusDX acquired Freedom Pathology Partners to further expand its national presence in providing anatomic pathology, molecular testing, and fluorescence in situ hybridization.
Anatomic Pathology Industry Report Scope
Future Market Insights latest report provides a detailed anatomic pathology market forecast for a period of 8 years (2022-2030). It examines how advancement in anatomic pathology is revolutionizing the disease diagnosis and drug discovery services markets
The report is intended to enlighten customers with significant details about market shaping factors including drivers, restraints, emerging opportunities and latest anatomic pathology market trends.
While developed nations like the United States, Germany, and the United Kingdom remain at the top of the ladder, factors pushing anatomic pathology industry growth across emerging economies such as India and China have been thoroughly discussed.
FMI also illustrates how rise in chronic diseases and increasing investments in R&D will expand the global anatomic pathology market size during the forthcoming years. Besides this, it offers insights into leading anatomic pathology manufacturers and their growth strategies.
The Anatomic Pathology Market Analysis Includes:
- An 8-year realistic sales forecast of anatomic pathology across several end use verticals
- Insights into futuristic anatomic pathology market projections
- Market dynamics including drivers, restraints, and emerging opportunities
- Details about key players operating in anatomic pathology market and their respective growth strategies to penetrate attractive markets
- Information about lucrative regional pockets and leading anatomic pathology market segments
- Recent advances in anatomic pathology market
- The winning imperatives in anatomic pathology market
- Opportunity assessment
- Pricing analysis
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2022-2030 |
|
Historic Data Available for |
2015-2021 |
|
Market Analysis |
USD Million for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
|
|
Key regions covered |
North America
Latin America
Western Europe
Eastern Europe
South Asia Pacific
Middle East & Africa GCC Countries
Rest of the World
|
|
End User |
|
|
Key companies profiled |
Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., F.Hoffmann-La Roche AG, Cardinal Health, Inc.,BioGenex, NeoGenomics, Bio SB, Agilent Technologies |
|
Customization & pricing |
Available upon request |
Key Segments of Anatomic Pathology Industry Survey
Anatomic Pathology Market by Product & Service:
- Anatomic Pathology Instruments
- Anatomic Pathology Consumables
- Anatomic Pathology Services
Anatomic Pathology Market by Application:
- Disease Diagnosis
- Drug Discovery and Development
- Others
Anatomic Pathology Market by End User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Anatomic Pathology Market by Region:
- North America Anatomic Pathology Market
- Latin America Anatomic Pathology Market
- Europe Anatomic Pathology Market
- East Asia Anatomic Pathology Market
- South Asia & Pacific Anatomic Pathology Market
- Middle East & Africa (MEA) Anatomic Pathology Market
Frequently Asked Questions
How big is the global anatomic pathology industry?
As per FMI, the global anatomic pathology market was valued at US$ 32.5 Mn in 2022.
What is the growth projection for anatomic pathology market?
The global anatomic pathology market is expected to grow at 8.2% CAGR during the forecast period between 2022 to 2030.
What is the projected valuation for anatomic pathology market?
The anatomic pathology market is projected to reach US$ 61.1 Mn by 2030.
Who are the leading players operating in anatomic pathology?
Laboratory Corporation of America Holdings, Sakura Finetek USA, Inc., BioGenex, Quest Diagnostics Incorporated, F.Hoffmann-La Roche AG, Cardinal Health, Inc., NeoGenomics, and Bio SB are some of the leading players operating in anatomic pathology market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 3.3. Innovations & New Launches 4. Market Context 4.1. Product USPs/ Features 4.2. Disease Epidemiology 4.3. Product USPs/ Features 4.4. Strategic Promotional Strategies 4.5. Regulatory Scenario 4.6. Product Adoption in Primary diagnosis 4.7. Regulatory Scenario 5. COVID19 Crisis Analysis 5.1. Current COVID19 Statistics and Probable Future Impact 5.2. Current GDP Projection and Probable Impact 5.3. Current Economic Projection as compared to 2008 financial analysis 5.4. COVID19 and Impact Analysis 5.4.1. Revenue By Product 5.4.2. Revenue By Area of Application 5.4.3. Revenue By Country 5.5. 2022 Market Scenario 5.6. Quarter by Quarter Forecast 5.7. Projected recovery Quarter 5.8. Recovery Scenario – Short term, Midterm and Long Term Impact 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Global GDP Growth Outlook 6.1.2. Global Healthcare Outlook 6.2. Forecast Factors - Relevance & Impact 6.2.1. Research and Developmental Activities 6.2.2. Technological Advancement 6.2.3. Adoption of Anatomic Pathology 6.2.4. Reimbursement in Anatomic Pathology 6.2.5. Advances in Preventative Diagnosis 6.2.6. Focus of Manufacturer to Launch Innovative Products 6.3. Market Dynamics 6.3.1. Drivers 6.3.2. Restraints 6.3.3. Opportunities 7. Global Anatomic Pathology Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product & Services Type 7.2. Pricing Break-up* 7.2.1. Provider Level Pricing 7.2.2. Service Level Pricing 7.3. Global Average Pricing Analysis Benchmark* 8. Global Anatomic Pathology Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030 8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Opportunity Analysis, 2022-2030 9. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By Product & Services Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Product & Services Type, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product & Services Type, 2022-2030 9.3.1. Instruments 9.3.1.1. Microtomes & Cryostat 9.3.1.2. Tissue processors 9.3.1.3. Automatic Stainers 9.3.1.4. Other products 9.3.2. Consumables 9.3.2.1. Reagents & Antibodies 9.3.2.2. Probes & Kits 9.3.2.3. Others 9.3.3. Services 9.3.3.1. Histopathology 9.3.3.2. Cytopathology 9.4. Market Attractiveness Analysis By Product & Services Type 10. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By Area of Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Area of Application, 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Area of Application, 2022-2030 10.3.1. Disease Diagnosis 10.3.2. Drug Discovery and Development 10.3.3. Others 10.4. Market Attractiveness Analysis By Area of Application 11. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030 11.3.1. Hospitals 11.3.2. Research Laboratories 11.3.3. Diagnostic Laboratories 11.3.4. Others 11.4. Market Attractiveness Analysis By End User 12. Global Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa 12.4. Market Attractiveness Analysis By Region 13. North America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product & Services Type 13.3.3. By Area of Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product & Services Type 14.3.3. By Area of Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Product & Services Type 15.3.3. By Area of Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product & Services Type 16.3.3. By Area of Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product & Services Type 17.3.3. By Area of Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product & Services Type 18.3.3. By Area of Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2021 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Turkey 19.3.1.3. South Africa 19.3.1.4. Rest of Middle East and Africa 19.3.2. By Product & Services Type 19.3.3. By Area of Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Anatomic Pathology Market Analysis 2015-2021 and Forecast 2022-2030 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Anatomic Pathology Market Analysis 20.2.1. By Product & Services Type 20.2.2. By Area of Application 20.2.3. By End User 20.3. Canada Anatomic Pathology Market Analysis 20.3.1. By Product & Services Type 20.3.2. By Area of Application 20.3.3. By End User 20.4. Mexico Anatomic Pathology Market Analysis 20.4.1. By Product & Services Type 20.4.2. By Area of Application 20.4.3. By End User 20.5. Brazil Anatomic Pathology Market Analysis 20.5.1. By Product & Services Type 20.5.2. By Area of Application 20.5.3. By End User 20.6. U.K. Anatomic Pathology Market Analysis 20.6.1. By Product & Services Type 20.6.2. By Area of Application 20.6.3. By End User 20.7. Germany Anatomic Pathology Market Analysis 20.7.1. By Product & Services Type 20.7.2. By Area of Application 20.7.3. By End User 20.8. France Anatomic Pathology Market Analysis 20.8.1. By Product & Services Type 20.8.2. By Area of Application 20.8.3. By End User 20.9. Italy Anatomic Pathology Market Analysis 20.9.1. By Product & Services Type 20.9.2. By Area of Application 20.9.3. By End User 20.10. Spain Anatomic Pathology Market Analysis 20.10.1. By Product & Services Type 20.10.2. By Area of Application 20.10.3. By End User 20.11. BENELUX Anatomic Pathology Market Analysis 20.11.1. By Product & Services Type 20.11.2. By Area of Application 20.11.3. By End User 20.12. Russia Anatomic Pathology Market Analysis 20.12.1. By Product & Services Type 20.12.2. By Area of Application 20.12.3. By End User 20.13. China Anatomic Pathology Market Analysis 20.13.1. By Product & Services Type 20.13.2. By Area of Application 20.13.3. By End User 20.14. Japan Anatomic Pathology Market Analysis 20.14.1. By Product & Services Type 20.14.2. By Area of Application 20.14.3. By End User 20.15. South Korea Anatomic Pathology Market Analysis 20.15.1. By Product & Services Type 20.15.2. By Area of Application 20.15.3. By End User 20.16. India Anatomic Pathology Market Analysis 20.16.1. By Product & Services Type 20.16.2. By Area of Application 20.16.3. By End User 20.17. ASEAN Anatomic Pathology Market Analysis 20.17.1. By Product & Services Type 20.17.2. By Area of Application 20.17.3. By End User 20.18. Australia Anatomic Pathology Market Analysis 20.18.1. By Product & Services Type 20.18.2. By Area of Application 20.18.3. By End User 20.19. New Zealand Anatomic Pathology Market Analysis 20.19.1. By Product & Services Type 20.19.2. By Area of Application 20.19.3. By End User 20.20. GCC Countries Anatomic Pathology Market Analysis 20.20.1. By Product & Services Type 20.20.2. By Area of Application 20.20.3. By End User 20.21. Turkey Anatomic Pathology Market Analysis 20.21.1. By Product & Services Type 20.21.2. By Area of Application 20.21.3. By End User 20.22. South Africa Anatomic Pathology Market Analysis 20.22.1. By Product & Services Type 20.22.2. By Area of Application 20.22.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence of Parallel Industries 21.4. Market Presence Analysis 21.4.1. Regional Footprint by Players 21.4.2. Product Foot print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive (Tentative List*) 22.3.1. F. Hoffmann-La Roche AG 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. Danaher Corporation 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Hologic, Inc 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Thermo Fisher Scientific, InC 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Agilent Technologies 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Becton, Dickinson and Company 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. PHP Holdings Corporation 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Sakura Finetek USA Inc 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Merck KGaA 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 22.3.10. Bio SB 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.10.5.1. Marketing Strategy 22.3.10.5.2. Product Strategy 22.3.10.5.3. Channel Strategy 22.3.11. Diapath S.p.A. 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.11.5.1. Marketing Strategy 22.3.11.5.2. Product Strategy 22.3.11.5.3. Channel Strategy 22.3.12. BioGenex Laboratories 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.12.5.1. Marketing Strategy 22.3.12.5.2. Product Strategy 22.3.12.5.3. Channel Strategy 22.3.13. Cardinal Health, Inc 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.13.5.1. Marketing Strategy 22.3.13.5.2. Product Strategy 22.3.13.5.3. Channel Strategy 22.3.14. Quest Diagnostics Incorporated 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Profitability by Market Segments (Product/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.14.5.1. Marketing Strategy 22.3.14.5.2. Product Strategy 22.3.14.5.3. Channel Strategy 22.3.15. Laboratory Corporation of America Holdings 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Profitability by Market Segments (Product/Channel/Region) 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 22.3.15.5.1. Marketing Strategy 22.3.15.5.2. Product Strategy 22.3.15.5.3. Channel Strategy 22.3.16. NeoGenomics Laboratories Inc 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Profitability by Market Segments (Product/Channel/Region) 22.3.16.4. Sales Footprint 22.3.16.5. Strategy Overview 22.3.16.5.1. Marketing Strategy 22.3.16.5.2. Product Strategy 22.3.16.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 02: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 03: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 04: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 05: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Region Table 06: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 07: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 08: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 09: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 10: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 11: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 12: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 13: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 14: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 15: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 16: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 17: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 18: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 19: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 20: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 21: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 22: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Typeh Table 23: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 24: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 25: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 26: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 27: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 28: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 29: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 30: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 31: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 32: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 33: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 34: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 35: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 36: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 37: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 38: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 39: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 40: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 41: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 42: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 43: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 44: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 45: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 46: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 47: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 48: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 49: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 50: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 51: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 52: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Table 01: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 02: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 03: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 04: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 05: Global Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Region Table 06: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 07: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 08: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 09: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 10: North America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 11: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 12: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 13: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 14: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 15: Latin America Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 16: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 17: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 18: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 19: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 20: Europe Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 21: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 22: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Typeh Table 23: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 24: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 25: East Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 26: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 27: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 28: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 29: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 30: South Asia Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 31: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 32: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 33: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 34: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 35: Oceania Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 36: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Country Table 37: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 38: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 39: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 40: MEA Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 41: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 42: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 43: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 44: China Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 45: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 46: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 47: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 48: India Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User Table 49: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 50: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Product & Services Type Table 51: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By Application Table 52: Brazil Anatomic Pathology Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030, By End User
Recommendations
Explore Healthcare Insights
View Reports
